生化科技研發業
暫不提供
暫不提供
台北市大安區信義路三段149號5樓
CMIC Asia-Pacific (its regional headquarter is in Singapore) assists both pharmaceutical and biotech companies with drug development and regulatory consultations worldwide, including Asian countries. We are expanding our business in Asia-Pacific region together with CMIC Co Ltd in Japan, CAP’s parent company. CMIC Group has competitive advantages in Asian studies as well as global studies for our clients.
CMIC Asia-Pacific offers a wide range of services for foreign pharmaceutical companies. Among other things, we have the followings: 1. Developing strategy formulation, including a feasibility study and a market assessment in Asian countries 2. Developing regulatory strategy and assisting in responding to authorities’ inquiries 3. Reviewing Pre-clinical and clinical data and conducting data gap analysis 4. Managing clinical trials in Asia and worldwide 5. Developing local versions of Protocols, CRFs, Informed Consent Form, Clinical Study Report etc. and conduct clinical trials in Asian countries 6. Evaluating a bridging strategy and an orphan drug designation 7. Assisting licensing in/out, and partnering opportunity
-Competitive salary package -Health insurance, government required retirement allowance, industrial accidental insurance -Other welfare programs as appropriate -Comprehensive training and continuing clinical education programs on a region-wide level -Growth potential is extensive and driven by candidate’s capabilities